Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Shiku

Showing results (271-280 of 330) with videos related to

Pageof 33
Sort By:
Thrombosis Research|October 5, 2001
Activity and antigen levels of thrombin-activatable fibrinolysis inhibitor in plasma of patients with disseminated intravascular coagulationR Watanabe, H Wada, Y Watanabe, et al.
Experimental Hematology|March 1, 1995
Decreased expression of protein phosphatase type 2A in HL-60 variant (HL-60RAr) cells resistant to induction of cell differentiation by all-trans retinoic acidS B Omay, M Nishikawa, K Morita, et al.
American Journal of Hematology|February 3, 1999
Increased truncated form of plasma tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulationM Shimura, H Wada, T Nakasaki, et al.
Leukemia & Lymphoma|May 9, 2001
Bcl-2 in cell-cycle regulation of hematopoietic cells by transforming growth factor-beta1N Katayama, N Mahmud, K Nishii, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|July 1, 1997
Increased soluble fibrin monomer and soluble thrombomodulin levels in non-insulin-dependent diabetes mellitusY Sumida, H Wada, M Fujii, et al.
British Journal of Haematology|June 10, 2000
Activity of interleukin 6 in the differentiation of monocytes to macrophages and dendritic cellsH Mitani, N Katayama, H Araki, et al.
Gene Therapy|June 25, 2002
HER2 peptide-specific CD8(+) T cells are proportionally detectable long after multiple DNA vaccinationsK Mukai, Y Yasutomi, M Watanabe, et al.
European Journal of Immunology|November 28, 2000
A novel human HER2-derived peptide homologous to the mouse K(d)-restricted tumor rejection antigen can induce HLA-A24-restricted cytotoxic T lymphocytes in ovarian cancer patients and healthy individualsT Okugawa, Y Ikuta, Y Takahashi, et al.
Endoscopy|April 22, 2005
Ileocolonic lymphomas: a series of 16 casesT Saito, H Toyoda, M Yamaguchi, et al.
Leukemia & Lymphoma|March 14, 1998
Role for C-MPL and its ligand thrombopoietin in early hematopoiesisN Katayama, R Itoh, T Kato, et al.
Pageof 33

Showing results (271-280 of 330) with videos related to

Sort By:
Pageof 33
Thrombosis Research|October 5, 2001
Activity and antigen levels of thrombin-activatable fibrinolysis inhibitor in plasma of patients with disseminated intravascular coagulationR Watanabe, H Wada, Y Watanabe, et al.
Experimental Hematology|March 1, 1995
Decreased expression of protein phosphatase type 2A in HL-60 variant (HL-60RAr) cells resistant to induction of cell differentiation by all-trans retinoic acidS B Omay, M Nishikawa, K Morita, et al.
American Journal of Hematology|February 3, 1999
Increased truncated form of plasma tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulationM Shimura, H Wada, T Nakasaki, et al.
Leukemia & Lymphoma|May 9, 2001
Bcl-2 in cell-cycle regulation of hematopoietic cells by transforming growth factor-beta1N Katayama, N Mahmud, K Nishii, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|July 1, 1997
Increased soluble fibrin monomer and soluble thrombomodulin levels in non-insulin-dependent diabetes mellitusY Sumida, H Wada, M Fujii, et al.
British Journal of Haematology|June 10, 2000
Activity of interleukin 6 in the differentiation of monocytes to macrophages and dendritic cellsH Mitani, N Katayama, H Araki, et al.
Gene Therapy|June 25, 2002
HER2 peptide-specific CD8(+) T cells are proportionally detectable long after multiple DNA vaccinationsK Mukai, Y Yasutomi, M Watanabe, et al.
European Journal of Immunology|November 28, 2000
A novel human HER2-derived peptide homologous to the mouse K(d)-restricted tumor rejection antigen can induce HLA-A24-restricted cytotoxic T lymphocytes in ovarian cancer patients and healthy individualsT Okugawa, Y Ikuta, Y Takahashi, et al.
Endoscopy|April 22, 2005
Ileocolonic lymphomas: a series of 16 casesT Saito, H Toyoda, M Yamaguchi, et al.
Leukemia & Lymphoma|March 14, 1998
Role for C-MPL and its ligand thrombopoietin in early hematopoiesisN Katayama, R Itoh, T Kato, et al.
Pageof 33